File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1021/mp800187d
- Scopus: eid_2-s2.0-64649104312
- PMID: 19718803
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Tumor targeting of functionalized quantum dot liposome hybrids by intravenous administration
Title | Tumor targeting of functionalized quantum dot liposome hybrids by intravenous administration |
---|---|
Authors | |
Keywords | Biodistribution Hybrid ICP-MS Liposomes Pharmacokinetics Quantum dots Tumor targeting |
Issue Date | 2009 |
Citation | Molecular Pharmaceutics, 2009, v. 6, n. 2, p. 520-530 How to Cite? |
Abstract | A strategy to target functionalized quantum dot-liposome (f-QD-L) hybrid vesicles in the solid tumor tissue of tumor-bearing mice is explored. Functionalized polyethylene glycol (PEG)- lipid coated QD (f-QD) were encapsulated into the aqueous core of 100 nm cationic (DOPC:Chol: DOTAP); sterically stabilized, fluid-phase (DOPC:Chol:DSPE-PEG2000); and sterically stabilized, gel- phase (DSPC:Chol:DSPE-PEG2000) liposome vesicles. Double tracking of f-QD-L in blood was performed at different time points after intravenous administration in B16F10 melanoma tumor- bearing C57BL6 mice. Cholesteryl [-1-14C] oleate lipids probed the vesicle membrane were followed by liquid scintillation counting while QD were determined independently by elemental (Cd2+) analysis using inductively coupled plasma mass spectrometry (ICP-MS). Rapid blood clearance was observed following intravenous administration of the cationic hybrid vesicles, while incorporation of PEG at the surface of zwitterionic vesicles dramatically prolonged their blood circulation half-life after systemic administration. The "rigid" PEGylated f-QD-L (DSPC:Chol:DSPE-PEG2000) hybrid vesicles led to rapid tumor accumulation of peak values (approximately 5% of injected dose per gram tissue) of QD compared to long-circulating f-QD that accumulated in the tumor tissue at longer time points. More interestingly, this hybrid vesicle tumor retention persisted for at least 24 h. For almost all types of systems, a preferential cadmium uptake by liver and spleen was obtained. Overall, f-QD-L hybrid vesicles offer great potential for tumor imaging applications due to their rapid accumulation and prolonged retention within the tumor. Furthermore, f-QD-L offer many opportunities for the development of combinatory therapeutic and imaging (theranostic) modalities by incorporating both drug molecules and QD within the different compartments of a single vesicle. © 2009 American Chemical Society. |
Persistent Identifier | http://hdl.handle.net/10722/348916 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 0.940 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Al-Jamal, Waf A.T. | - |
dc.contributor.author | Al-Jamal, Khuloud T. | - |
dc.contributor.author | Tian, Bowen | - |
dc.contributor.author | Cakebread, Andrew | - |
dc.contributor.author | Halket, John M. | - |
dc.contributor.author | Kostarelos, Kostas | - |
dc.date.accessioned | 2024-10-17T06:54:55Z | - |
dc.date.available | 2024-10-17T06:54:55Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | Molecular Pharmaceutics, 2009, v. 6, n. 2, p. 520-530 | - |
dc.identifier.issn | 1543-8384 | - |
dc.identifier.uri | http://hdl.handle.net/10722/348916 | - |
dc.description.abstract | A strategy to target functionalized quantum dot-liposome (f-QD-L) hybrid vesicles in the solid tumor tissue of tumor-bearing mice is explored. Functionalized polyethylene glycol (PEG)- lipid coated QD (f-QD) were encapsulated into the aqueous core of 100 nm cationic (DOPC:Chol: DOTAP); sterically stabilized, fluid-phase (DOPC:Chol:DSPE-PEG2000); and sterically stabilized, gel- phase (DSPC:Chol:DSPE-PEG2000) liposome vesicles. Double tracking of f-QD-L in blood was performed at different time points after intravenous administration in B16F10 melanoma tumor- bearing C57BL6 mice. Cholesteryl [-1-14C] oleate lipids probed the vesicle membrane were followed by liquid scintillation counting while QD were determined independently by elemental (Cd2+) analysis using inductively coupled plasma mass spectrometry (ICP-MS). Rapid blood clearance was observed following intravenous administration of the cationic hybrid vesicles, while incorporation of PEG at the surface of zwitterionic vesicles dramatically prolonged their blood circulation half-life after systemic administration. The "rigid" PEGylated f-QD-L (DSPC:Chol:DSPE-PEG2000) hybrid vesicles led to rapid tumor accumulation of peak values (approximately 5% of injected dose per gram tissue) of QD compared to long-circulating f-QD that accumulated in the tumor tissue at longer time points. More interestingly, this hybrid vesicle tumor retention persisted for at least 24 h. For almost all types of systems, a preferential cadmium uptake by liver and spleen was obtained. Overall, f-QD-L hybrid vesicles offer great potential for tumor imaging applications due to their rapid accumulation and prolonged retention within the tumor. Furthermore, f-QD-L offer many opportunities for the development of combinatory therapeutic and imaging (theranostic) modalities by incorporating both drug molecules and QD within the different compartments of a single vesicle. © 2009 American Chemical Society. | - |
dc.language | eng | - |
dc.relation.ispartof | Molecular Pharmaceutics | - |
dc.subject | Biodistribution | - |
dc.subject | Hybrid | - |
dc.subject | ICP-MS | - |
dc.subject | Liposomes | - |
dc.subject | Pharmacokinetics | - |
dc.subject | Quantum dots | - |
dc.subject | Tumor targeting | - |
dc.title | Tumor targeting of functionalized quantum dot liposome hybrids by intravenous administration | - |
dc.type | Article | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1021/mp800187d | - |
dc.identifier.pmid | 19718803 | - |
dc.identifier.scopus | eid_2-s2.0-64649104312 | - |
dc.identifier.volume | 6 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 520 | - |
dc.identifier.epage | 530 | - |
dc.identifier.eissn | 1543-8392 | - |